Patent Armory v. Biobot Analytics: Five Routing Patents Dismissed in 37 Days
Patent Armory, Inc. asserted five patents covering intelligent communication routing and telephony control systems against Biobot Analytics, Inc. in Delaware. The parties reached a stipulated dismissal with prejudice in just 37 days — one of the shortest resolution windows in Delaware District Court patent litigation — with each side bearing its own costs.
Filing to Dismissed with Prejudice in 37 days
37 days — resolved far faster than the median Delaware patent case (typically 18–24 months)
Dismissed with prejudice: what the split stipulation means for both parties
Rule 41(a)(1)(A)(ii) stipulated dismissal — split prejudice terms
Under FRCP 41(a)(1)(A)(ii), parties may jointly stipulate to dismiss without court approval. Here, plaintiff’s claims against Biobot were dismissed with prejudice — permanently barring re-filing — while Biobot’s counterclaims were dismissed without prejudice, preserving Biobot’s right to reassert them. This asymmetric structure is a notable feature of the agreed terms.
Split prejudice stipulationPatent Armory surrenders the right to re-sue Biobot on these patents
A with-prejudice dismissal of the plaintiff’s claims means Patent Armory cannot bring the same infringement claims against Biobot Analytics on any of the five asserted patents again. This is a significant concession. It suggests either a negotiated resolution was reached (terms undisclosed) or Patent Armory determined the litigation risk outweighed the enforcement opportunity against this specific defendant.
Claims permanently extinguishedBiobot retains counterclaim rights; no costs awarded against it
Biobot Analytics’ counterclaims — likely invalidity and/or non-infringement challenges — were dismissed without prejudice, meaning Biobot retains the ability to reassert them if litigation resumes on related grounds. Combined with the no-fee-shifting provision, Biobot exits the case in a relatively strong procedural position, having avoided any merits adjudication on the patents.
Counterclaims preservedNo validity ruling — all five patents remain fully enforceable against others
Because the case ended by stipulation without any merits ruling, the five asserted patents — covering intelligent call routing, entity-matching auction methods, and telephony control — remain valid and enforceable. Patent Armory is free to assert them against other defendants. Companies operating communication routing or wastewater analytics platforms incorporating telephony features should treat these patents as active enforcement risk.
Patents remain live enforcement riskFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Patent Armory, Inc. | Company | Search in Eureka ↗ |
| Defendant | Biobot Analytics, Inc. | Company | Search in Eureka ↗ |
| Plaintiff counsel | Antranig N. Garibian | Attorney | Counsel for Patent Armory, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Garibian Law Offices, PC | Law Firm | Representing Patent Armory, Inc.Search in Eureka ↗ |
| Defendant counsel | Jeremy Douglas Anderson | Attorney | Counsel for Biobot Analytics, Inc.Search in Eureka ↗ |
| Defendant law firm | Fish & Richardson PC | Law Firm | Representing Biobot Analytics, Inc.Search in Eureka ↗ |
| Presiding judge | Judge Maryellen Noreika | Judge | Delaware District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulation’s asymmetric prejudice structure is legally precise: Patent Armory’s infringement claims are permanently extinguished as against Biobot, while Biobot’s counterclaims — likely invalidity challenges — survive for potential future assertion. No court made any finding on the merits. The mutual cost-bearing clause rules out an exceptional-case fee award under 35 U.S.C. § 285, and the absence of any damages figure suggests this was a pre-discovery resolution, consistent with either an undisclosed licensing payment or a strategic withdrawal.
US9456086B1 and four further patents — intelligent communication routing and telephony control
The five asserted patents span two overlapping technical domains: intelligent call and communication routing (US9456086B1, US10491748B1, US7269253B1, US7023979B1) and auction-based entity matching (US10237420B1). The routing patents trace application dates from the mid-2000s through to 2017, suggesting a portfolio built across multiple filing generations. The earliest applications pre-date widespread VoIP and cloud-contact-centre deployment, which may affect claim scope interpretations under modern architectures.
For competitors and product teams, the breadth of this five-patent portfolio is strategically significant. Intelligent routing claims can read on contact-centre platforms, IVR systems, automated call distribution, and increasingly on AI-driven communication orchestration tools. The auction-matching patent adds a layer relevant to programmatic communication or lead-routing platforms. Patent Armory’s willingness to assert these patents against a wastewater analytics company — Biobot Analytics — suggests a broad interpretation of the claims’ applicability across industries incorporating voice or data routing infrastructure.
Should you run an FTO against US9456086B1 and Patent Armory’s routing portfolio?
Any company developing or deploying intelligent communication routing, automated call distribution, IVR, contact-centre orchestration, or entity-matching platforms should consider an FTO assessment against Patent Armory’s five-patent stack. The Biobot case demonstrates that Patent Armory is willing to assert these patents against defendants whose primary business is not telephony — meaning the claimed scope is being interpreted broadly. Pre-product-launch FTO is particularly advisable for startups and scale-ups in the communications infrastructure or analytics-with-routing space.
PatSnap Eureka’s FTO Search Agent can map each of the five asserted claims against your product architecture, flag design-around opportunities, and surface prior art that could support an invalidity position. Given that Biobot’s counterclaims were preserved without prejudice, there may be prior art arguments that were prepared but never filed — Eureka can help identify those arguments before you face your own demand letter from Patent Armory or a similarly structured NPE portfolio.
Run a freedom-to-operate analysis on US9456086B1 to assess your product’s exposure
Run FTO in Eureka →Similar intelligent routing and telephony patent cases in Delaware District Court
Explore comparable NPE-driven intelligent communication routing and telephony patent infringement actions filed in the District of Delaware with similar stipulated dismissal outcomes.
What this case signals for the communication routing IP landscape
A 37-day dismissal on five routing patents in Delaware raises questions about enforcement strategy and portfolio breadth.
Ultra-fast dismissals often signal pre-suit licensing activity or rapid settlement
When a patent assertion case collapses within 37 days — before any substantive motion practice — it typically suggests either a licensing agreement was reached quietly, the plaintiff assessed litigation risk as unfavourable, or the defendant’s early invalidity arguments proved persuasive. The public record is silent on which factor drove the outcome here.
With-prejudice dismissal of plaintiff’s claims is a meaningful concession worth monitoring
Patent Armory’s acceptance of a with-prejudice bar against Biobot specifically, while retaining the patents for other enforcement, is consistent with a targeted settlement. IP professionals tracking Patent Armory’s portfolio should note which defendants receive with-prejudice versus without-prejudice terms as a signal of portfolio monetisation strategy.
Patent v Biobot — key questions answered
Patent Armory filed a patent infringement action against Biobot Analytics in Delaware on 4 December 2024, asserting five patents covering intelligent communication routing and telephony control systems. The parties filed a Rule 41(a)(1)(A)(ii) stipulation on 10 January 2025, dismissing all of Patent Armory’s claims with prejudice and all of Biobot’s counterclaims without prejudice. The case lasted 37 days with each party bearing its own costs.
Patent Armory asserted five US patents: US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1. These patents cover intelligent communication routing systems, telephony control with intelligent call routing, and a method and system for matching entities in an auction. Application numbers span from the mid-2000s through 2017.
A with-prejudice dismissal permanently bars Patent Armory from re-filing the same infringement claims against Biobot Analytics on the five asserted patents. Patent Armory cannot bring a new action against Biobot on these specific patents in the future. However, the patents themselves remain valid and enforceable against other defendants.
The stipulation specifically preserved Biobot’s counterclaims by dismissing them without prejudice, meaning Biobot retains the right to reassert them — most likely invalidity or non-infringement arguments — in future proceedings if necessary. This asymmetric structure suggests Biobot negotiated protective terms, ensuring it was not permanently bound by any implied concession on the merits of its defences.
No. The stipulated dismissal was procedural and carried no merits adjudication. No court ruled on infringement, validity, or claim scope. All five asserted patents — US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 — remain granted, presumed valid under 35 U.S.C. § 282, and enforceable against other parties in future litigation.
PatSnap Eureka searches patents and litigation data to answer instantly.